Perceptive Advisors’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Perceptive Advisors’s Portfolio TBIO Stock Details TBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-315,237	Closed	-$4.29M	–	157
2020 Q3	$4.29M	Hold	315,237	–	–	0.06%	104
2020 Q2	$5.65M	Sell	315,237 -119,763	-28%	-$1.81M	0.09%	93
2020 Q1	$4.99M	Hold	435,000	–	–	0.13%	77
2019 Q4	$3.54M	Hold	435,000	–	–	0.07%	85
2019 Q3	$4.31M	Hold	435,000	–	–	0.12%	73
2019 Q2	$5.49M	Hold	435,000	–	–	0.13%	79
2019 Q1	$4.43M	Hold	435,000	–	–	0.13%	70
2018 Q4	$3.17M	Sell	435,000 -65,000	-13%	-$476K	0.12%	70
2018 Q3	$5M	Hold	500,000	–	–	0.13%	72
2018 Q2	$6.33M	Buy	+500,000	New	+$6.04M	0.17%	68

Other funds holding TBIO

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

AVA

Atlas Venture Advisors Boston, Massachusetts $122M AUM 26.28% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Perceptive Advisors's TBIO Position: Q4 2020 in Review

Perceptive Advisors sold out of Translate Bio, Inc. Common Stock (TBIO) in Q4 2020, closing a stake of 315,237 shares — an estimated $4.29M sold.

Perceptive Advisors first reported a position in TBIO in Q2 2018 and held it in 10 quarters. The position peaked at $6.33M in Q2 2018. 150 funds tracked by Wall St. Rank hold TBIO as of Q4 2020.

Perceptive Advisors reported no remaining Translate Bio, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
Perceptive Advisors sold 315,237 Translate Bio, Inc. Common Stock shares in Q4 2020, an estimated $4.29M.
Perceptive Advisors first reported a position in Translate Bio, Inc. Common Stock in Q2 2018 and held it in 10 quarters.
Perceptive Advisors's Translate Bio, Inc. Common Stock position peaked at $6.33M in Q2 2018.
150 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q4 2020.

Based on Perceptive Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.